Medical Uses of Venom

Though the bites and stings of snakes and other creatures can be deadly, researchers have identified compounds and proteins in the venom of some species with potential medical applications. Treatments to slow the growth of some forms of cancer, alleviate chronic pain, and slow the progression of Alzheimer’s disease are in development, and experts are working to identify other possible applications for venoms and animal-derived toxins.

According to John Perez, director of the National Toxins Research Center at Texas A&M University-Kingsville, “Snakes use venom to alter biological functions, and that’s what medicine does too.” The venom of some snakes has been found to have antibacterial applications, as well as slowing cell growth, increasing nerve stimulation, and affecting blood thinning and clotting. Preliminary research has shown that a compound found in the venom of some snakes may be able to inhibit cancer cell migration and slow the growth of tumor cells. Moreover, the anti-clotting proteins that contribute to the lethalness of a snake’s bite have been studied for their possible application as medications for high blood pressure and anti-clotting drugs.

In addition to snake venoms, toxins from a number of other animals have also been found to have medical applications. The saliva of the Gila monster is being studied as a possible drug for the treatment of type 2 diabetes, and proteins which can inhibit or stimulate the growth of blood vessels have been identified within the venom of several amphibians. Naturally occurring and synthesized venom from cone snails are being examined as new treatments for pain, epilepsy, and incontinence. As is the case also in snakes, experts note that there are more than 500 species of cone snail, and that each is able to produce more than 100 unique toxins, all of which could have beneficial medical applications.

Toxins from a number of arachnids and insects have also been examined. Historically bee venom has been used to treat a number of ailments, and in recent years bee venom therapy (BVT) or apitherapy has been touted as a treatment for arthritis, chronic pain, migraines, and multiple sclerosis. Compounds found in scorpion venom which disrupt the growth and spread of invasive tumors have been investigated for possible applications in treating brain cancer. Venoms from spiders have also been studied and research is ongoing to determine if they could be utilized to prevent arterial fibrillation after a heart attack, to regulate and control blood pressure, or to treat erectile dysfunction.

With additional research, it may be possible to identify new treatments for cancer or even HIV/AIDS among the compounds in venoms and toxins. By working to better understand the wealth of resources of the world’s biodiversity, it may be possible to improve global health.

Discuss this and other health topics in the iCons in Medicine Forums

HIV/AIDS Progress

In the 30 years since it was first identified, the global response to AIDS has achieved significant results. More people than ever before have access to treatment, allowing them to manage their condition, and according to the United Nations rates of new HIV infections are falling by nearly 25 percent. In spite of these successes, it is important that efforts continue to ensure that progress is made towards further improving treatment options and outcomes.

Since 1981, a reported 25 million people worldwide have died from AIDS and an additional 34 million are infected with HIV. According to a recent United Nations report, in the 33 worst-affected countries, the rate of new HIV infections fell by 25 percent between 2001 and 2009, and in India and South Africa, the countries with the largest populations of individuals living with HIV, new infections fell by 50 percent and 35 percent, respectively. According to Michel Sidibé, Executive Director of UNAIDS, through the use of antiretroviral therapy (ART), “AIDS has moved from what was effectively a death sentence to a chronic disease…Antiretroviral therapy is a bigger game-changer than ever before – it not only stops people from dying, but also prevents the transmission of HIV to women, men and children.”

A decade ago, half of the population of several nations in southern Africa were expected to die of AIDS-related causes, but as ART has become more widely available, the death rate is dropping. An estimated 6.6 million people in low- and middle-income countries were receiving ART at the end of 2010 – a nearly 22-fold increase since 2001. In spite of this increase, reports indicate that there are 16 million people worldwide living with HIV/AIDS who could benefit from these medications but many do not receive them. Even in the United States and other developed nations, individuals living with HIV/AIDS are frequently put on long waiting lists to gain access to these life-saving drugs as the supply is not able to meet the demand for them.

While expanded access to ART can help to improve the lives of individuals with HIV/AIDS and help to prevent new infection, a major gap in treatment still exists. Access to treatment for children is significantly lower than for adults, and only 28 percent of all eligible children were receiving treatment in 2009, compared with 36 percent for people of all ages. In addition, while the rate of new HIV infections globally has declined, the total number of individuals with HIV remains high and certain groups, including women of reproductive age, remain at increased risk of infection. By ensuring that antiretroviral medications and education and treatment programs are widely available, it may be possible to further decrease the number of new HIV/AIDS infections worldwide as researchers continue to work to track the spread of the disease and find a cure.



Discuss this and other public health topics in the iCons in Medicine forums